CAR T-Cell and Bispecific Therapy for Lymphoma — Part 3 of Our 6-Part ASH 2024 Friday Satellite Symposia Series
Hematologic Oncology Update
00:00
Assessing CAR T-Cell Therapy Eligibility in Older Patients
This chapter explores the suitability of CAR T-cell therapy for older patients, particularly through the case of a 79-year-old with comorbidities. It argues that age should not be the sole disqualifier for treatment, emphasizing the importance of overall health and performance status in the decision-making process.
Transcript
Play full episode
